Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer.

Waite, A; Balkman, C; Bailey, D; Kiselow, M; Flory, A; Beaulieu, B B; Lewis, L D; McEntee, M

Waite, A; Balkman, C; Bailey, D; Kiselow, M; Flory, A; Beaulieu, B B; Lewis, L D; McEntee, M.

Affiliation

Waite A; Cornell University Hospital for Animals, College of Veterinary Medicine, Ithaca, NY, USA.

Vet Comp Oncol ; 12(2): 160-8, 2014 Jun.

Article in En | MEDLINE | ID: mdl-22905693

Subject(s)

Antineoplastic Agents/therapeutic use; Cyclosporine/therapeutic use; Dermatologic Agents/therapeutic use; Dog Diseases/drug therapy; Skin Neoplasms/veterinary; Taxoids/therapeutic use; Administration, Oral; Animals; Antineoplastic Agents/administration & dosage; Cyclosporine/administration & dosage; Dermatologic Agents/administration & dosage; Docetaxel; Dogs; Drug Therapy, Combination; Female; Male; Skin Neoplasms/drug therapy; Taxoids/administration & dosage

Key words

chemotherapy; oncology; small animal; supportive care; tumour biology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Cyclosporine / Taxoids / Dermatologic Agents / Dog Diseases / Antineoplastic Agents Limits: Animals Language: En Journal: Vet Comp Oncol Journal subject: MEDICINA VETERINARIA / NEOPLASIAS Year: 2014 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google